Safety Study of Anti-IgE Immunotherapy in Allergic Patients
Clinical trial NCT00439621 · COMPLETED
Trial details
- NCT number
- NCT00439621
- Sponsor
- Resistentia Pharmaceuticals AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2008-03-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.